Wave Life Sciences Ltd.

48
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SG9999014716
USD
11.63
0.01 (0.09%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Wave Life Sciences Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
-204.00
-97.00
-58.00
-161.00
-122.00
-150.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-16.00
-75.00
19.00
6.00
7.00
9.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
-187.00
-151.00
-19.00
-127.00
-88.00
-115.00
Cash Flow from Investing Activities
0.00
0.00
-1.00
-1.00
0.00
-1.00
Cash Flow from Financing Activities
488.00
253.00
132.00
67.00
55.00
154.00
Net Cash Inflow / Outflow
300.00
101.00
111.00
-62.00
-33.00
37.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Wave Life Sciences Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-204.37800000102
-43.389
-161.00
-371.04%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-16.9400000000845
-3.716
-13.00
-355.87%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
-187.493000000935
-39.563
-148.00
-373.91%
Cash Flow from Investing Activities
-0.718000000003583
29.442
-29.00
-102.44%
Cash Flow from Financing Activities
488.235000002436
3.437
485.00
14105.27%
Net Cash Inflow / Outflow
300.036000001497
-6.684
306.00
4588.87%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0.0120000000000598
0
0.00
0.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -24.15% vs -677.24% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
-187.49
-151.03
-24.15%